Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
O. Kandemir, V. Oztuna, M. Colak, A. Akdag & H. Camdeviren. (2008) Comparison of the Efficacy of Tigecycline and Teicoplanin in an Experimental Methicillin-Resistant Staphylococcus aureus Osteomyelitis Model. Journal of Chemotherapy 20:1, pages 53-57.
Read now
Read now
Douglas N Fish. (2006) Meropenem in the treatment of complicated skin and soft tissue infections. Therapeutics and Clinical Risk Management 2:4, pages 401-415.
Read now
Read now
Articles from other publishers (14)
Zhe Gao, Yang Xu, Yuchen Kan, Hailong Li, Rui Guo, Luyang Han, Wenhan Bu & Jianjun Chu. (2023) Comparison of antibacterial activity and biocompatibility of non-leaching nitrofuran bone cement loaded with vancomycin, gentamicin, and tigecycline. Journal of Orthopaedic Surgery and Research 18:1.
Crossref
Crossref
S. Di Bella, C. Nisii & N. Petrosillo. (2015) Is tigecycline a suitable option for Clostridium difficile infection? Evidence from the literature. International Journal of Antimicrobial Agents 46:1, pages 8-12.
Crossref
Crossref
Christine M. Bassis, Casey M. Theriot & Vincent B. Young. (2014) Alteration of the Murine Gastrointestinal Microbiota by Tigecycline Leads to Increased Susceptibility to Clostridium difficile Infection. Antimicrobial Agents and Chemotherapy 58:5, pages 2767-2774.
Crossref
Crossref
Allena Ji Ji, James Patrick Saunders, Peter Amorusi, Gary Stein, Nandan Dilip Wadgaonkar, Kenneth Patrick O’Leary, Mauricio Leal & Eric Norbert Fluhler. (2010) Determination of tigecycline in human skin using a novel validated LC–MS/MS method. Bioanalysis 2:1, pages 81-94.
Crossref
Crossref
E. Bouza. (2009) New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus. Clinical Microbiology and Infection 15, pages 44-52.
Crossref
Crossref
S. Roveta, A. Marchese & E.A. Debbia. (2008) Tigecycline in vitro Activity against Gram-Negative and Gram-Positive Pathogens Collected in Italy. Chemotherapy 54:1, pages 43-49.
Crossref
Crossref
J. A. Passarell, A. K. Meagher, K. Liolios, B. B. Cirincione, S. A. Van Wart, T. Babinchak, E. J. Ellis-Grosse & P. G. Ambrose. (2008) Exposure-Response Analyses of Tigecycline Efficacy in Patients with Complicated Intra-Abdominal Infections. Antimicrobial Agents and Chemotherapy 52:1, pages 204-210.
Crossref
Crossref
Christopher M. Rubino, Lei Ma, Sujata M. Bhavnani, Joan Korth-Bradley, John Speth, Evelyn Ellis-Grosse, Keith R. Rodvold, Paul G. Ambrose & George L. Drusano. (2007) Evaluation of Tigecycline Penetration into Colon Wall Tissue and Epithelial Lining Fluid Using a Population Pharmacokinetic Model and Monte Carlo Simulation. Antimicrobial Agents and Chemotherapy 51:11, pages 4085-4089.
Crossref
Crossref
P.M. Olaechea Astigarraga, J. Garnacho Montero, S. Grau Cerrato, O. Rodríguez Colomo, M. Palomar Martínez, R. Zaragoza Crespo, P. Muñoz García-Paredes, E. Cerdá Cerdá & F. Álvarez Lerma. (2007) Recomendaciones GEIPC-SEIMC y GTEI-SEMICYUC para el tratamiento antibiótico de infecciones por cocos grampositivos en el paciente crítico. Medicina Intensiva 31:6, pages 294-317.
Crossref
Crossref
P.M. Olaechea Astigarraga, J. Garnacho Montero, S. Grau Cerrato, O. Rodríguez Colomo, M. Palomar Martínez, R. Zaragoza Crespo, P. Muñoz García-Paredes, E. Cerdá Cerdá & F. Álvarez Lerma. (2007) Recomendaciones GEIPC-SEIMC y GTEI-SEMICYUC para el tratamiento antibiótico de infecciones por cocos grampositivos en el paciente crítico. Enfermedades Infecciosas y Microbiología Clínica 25:7, pages 446-466.
Crossref
Crossref
A. J. Grisold, I. Wendelin, E. Presterl, R. B. Raggam, L. Masoud, A. Badura & E. Marth. (2007) In vitro activity of ten antibiotics, including tigecycline, against Bacteroides species in Austria. European Journal of Clinical Microbiology & Infectious Diseases 26:7, pages 525-527.
Crossref
Crossref
A. K. Meagher, J. A. Passarell, B. B. Cirincione, S. A. Van Wart, K. Liolios, T. Babinchak, E. J. Ellis-Grosse & P. G. Ambrose. (2007) Exposure-Response Analyses of Tigecycline Efficacy in Patients with Complicated Skin and Skin-Structure Infections. Antimicrobial Agents and Chemotherapy 51:6, pages 1939-1945.
Crossref
Crossref
Adam P. Fraise. (2006) Tigecycline: The answer to beta-lactam and fluoroquinolone resistance?. Journal of Infection 53:5, pages 293-300.
Crossref
Crossref
R. Zaragoza-Crespo & J.I. Blanes-Mompó. (2006) Infección y pie diabético. ¿Existen nuevas posibilidades terapéuticas?. Angiología 58:5, pages 347-356.
Crossref
Crossref